NO960699D0 - Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner - Google Patents

Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner

Info

Publication number
NO960699D0
NO960699D0 NO960699A NO960699A NO960699D0 NO 960699 D0 NO960699 D0 NO 960699D0 NO 960699 A NO960699 A NO 960699A NO 960699 A NO960699 A NO 960699A NO 960699 D0 NO960699 D0 NO 960699D0
Authority
NO
Norway
Prior art keywords
pyrimidinylpiperazines
indolylalkylpyridinyl
antimigren
thiadiazole derivatives
thiadiazole
Prior art date
Application number
NO960699A
Other languages
English (en)
Other versions
NO305248B1 (no
NO960699L (no
Inventor
Ronnie R Crenshaw
Edward H Ruediger
David W Smith
Carola Solomon
Joseph Yevich
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO960699D0 publication Critical patent/NO960699D0/no
Publication of NO960699L publication Critical patent/NO960699L/no
Publication of NO305248B1 publication Critical patent/NO305248B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO960699A 1995-03-02 1996-02-22 Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende dem NO305248B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/396,825 US5618816A (en) 1995-03-02 1995-03-02 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines

Publications (3)

Publication Number Publication Date
NO960699D0 true NO960699D0 (no) 1996-02-22
NO960699L NO960699L (no) 1996-09-03
NO305248B1 NO305248B1 (no) 1999-04-26

Family

ID=23568771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960699A NO305248B1 (no) 1995-03-02 1996-02-22 Antimigrene 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner og anvendelse derav, samt farmas°ytiske preparater inneholdende dem

Country Status (17)

Country Link
US (1) US5618816A (no)
EP (1) EP0729958A2 (no)
JP (1) JPH08253479A (no)
KR (1) KR960034200A (no)
CN (1) CN1063177C (no)
AR (1) AR002281A1 (no)
AU (1) AU707770B2 (no)
CA (1) CA2169804A1 (no)
CZ (1) CZ46896A3 (no)
HU (1) HUP9600498A3 (no)
IL (1) IL117224A (no)
NO (1) NO305248B1 (no)
NZ (1) NZ286090A (no)
PL (1) PL313022A1 (no)
RU (1) RU2165420C2 (no)
TW (1) TW331558B (no)
ZA (1) ZA961392B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694226B2 (en) * 1994-05-19 1998-07-16 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US7332183B2 (en) * 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
WO2004110492A2 (en) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition comprising triptans and nsaids
EP3027607B1 (en) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
US4600779A (en) * 1982-03-29 1986-07-15 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
GB9410031D0 (en) * 1994-05-19 1994-07-06 Merck Sharp & Dohme Therapeutic agents
AU694226B2 (en) * 1994-05-19 1998-07-16 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
NO305248B1 (no) 1999-04-26
NZ286090A (en) 1997-12-19
HUP9600498A2 (en) 1997-10-28
HU9600498D0 (en) 1996-04-29
TW331558B (en) 1998-05-11
CN1138042A (zh) 1996-12-18
ZA961392B (en) 1997-08-21
AR002281A1 (es) 1998-03-11
CN1063177C (zh) 2001-03-14
JPH08253479A (ja) 1996-10-01
IL117224A0 (en) 1996-06-18
HUP9600498A3 (en) 1998-10-28
EP0729958A2 (en) 1996-09-04
IL117224A (en) 2000-06-29
CA2169804A1 (en) 1996-09-03
EP0729958A3 (no) 1996-10-02
AU4581996A (en) 1996-09-12
AU707770B2 (en) 1999-07-22
KR960034200A (ko) 1996-10-22
RU2165420C2 (ru) 2001-04-20
NO960699L (no) 1996-09-03
PL313022A1 (en) 1996-09-16
US5618816A (en) 1997-04-08
CZ46896A3 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
NO953244D0 (no) Derivater av cyklodepeptid PF 1022
NO983004L (no) Laktonderivater av 17<beta>-karboksy-karbotio- og amidandrostanderivater
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
DE69513831D1 (de) Semicarbazid-derivate und diese enthaltende coatings
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
PT1140835E (pt) Derivados da 3,3-biarilpiperidina e 2,2-biarilmorfolina
NO960699D0 (no) Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
DK0821692T3 (da) Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
NO961404D0 (no) 4-indolylpiperazinyl-derivater
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
MX9201635A (es) Derivados de indol y di hidro quinolina.
MA23795A1 (fr) Derives d'indole substitues
NO306212B1 (no) Oligosakkarid selektivt for 1,3-L-fucosyltransferase samt anvendelse av samme
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
BR9508669A (pt) Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina
KR970009963U (ko) 2축형 경첩
SG35507A1 (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater
DE69612122D1 (de) Herstellung von 6-brom-2-methoxynaphthalin und derivaten
PL330590A1 (en) Novel derivatives of 7-bromo- and 7,7-dibromocephame and cepheme

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees